Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Bioqual	Cleveland BioLabs	Eloxx Pharmaceuticals	ProMIS Neurosciences	NanoViricides
Symbol	OTCMKTS:BIOQ	NASDAQ:CBLI	NASDAQ:ELOX	OTCMKTS:ARFXF	NYSEAMERICAN:NNVC
Price Information
Current Price	$91.00	$5.49	$1.89	$0.15	$3.63
52 Week Range	N/A	N/A	Buy	N/A	N/A
MarketRank™
Overall Score	0.9	0.6	1.4	0.0	0.4
Analysis Score	0.0	0.0	3.3	0.0	0.0
Community Score	2.6	3.2	2.9	0.0	2.1
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.8	0.0	0.0	0.0	0.0
Earnings & Valuation Score	1.3	0.0	0.6	0.0	0.0
Analyst Ratings
Consensus Recommendation	N/A	N/A	Buy	N/A	N/A
Consensus Price Target	N/A	N/A	$6.50	N/A	N/A
% Upside from Price Target	N/A	N/A	243.92% upside	N/A	N/A
Trade Information
Market Cap	$76.61 million	$84.93 million	$76.01 million	$43.37 million	$38.76 million
Beta	-0.33	0.61	2.57	0.93	0.67
Average Volume	358	320,998	99,834	296,160	1,879,614
Sales & Book Value
Annual Revenue	$46.36 million	$1.11 million	N/A	N/A	N/A
Price / Sales	1.76	76.51	N/A	N/A	N/A
Cashflow	$4.59 per share	N/A	N/A	N/A	N/A
Price / Cash	19.81	N/A	N/A	N/A	N/A
Book Value	$27.46 per share	$0.09 per share	$0.91 per share	N/A	$2.04 per share
Price / Book	3.31	61.00	N/A	N/A	N/A
Profitability
Net Income	$4.23 million	$-2,650,000.00	$-50,870,000.00	$-5,570,000.00	$-13,450,000.00
EPS	N/A	N/A	($1.34)	N/A	N/A
Trailing P/E Ratio	17.37	0.00	N/A	N/A	0.00
Forward P/E Ratio	∞	∞	N/A	∞	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	9.12%	-382.26%	N/A	N/A	N/A
Return on Equity (ROE)	17.62%	-123.97%	-163.87%	N/A	-43.79%
Return on Assets (ROA)	9.81%	-86.26%	-89.65%	-436.74%	-38.50%
Dividend
Annual Payout	$1.10	N/A	N/A	N/A	N/A
Dividend Yield	1.21%	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	0.52%	N/A	N/A
Current Ratio	N/A	6.66%	3.23%	0.20%	11.80%
Quick Ratio	N/A	6.66%	3.23%	0.20%	11.80%
Ownership Information
Institutional Ownership Percentage	N/A	2.59%	21.49%	0.03%	7.32%
Insider Ownership Percentage	39.24%	1.03%	33.40%	N/A	5.60%
Miscellaneous
Employees	N/A	2	25	N/A	17
Shares Outstanding	896,000	15.47 million	40.22 million	305.95 million	10.68 million
Next Earnings Date	9/21/2021 (Estimated)	5/21/2021 (Estimated)	8/5/2021 (Estimated)	5/12/2021 (Estimated)	6/28/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Optionable	Not Optionable	Optionable

Source	Headline
	Marburgvirus Infection Market: Facts, Figures and Analytical Insights, 2020 to 2027\| Emergent BioSolutions Inc, NanoViricides Inc, Theravectys SA and Others - Clark County Blog clarkcountyblog.com - May 6 at 2:36 AM
	Global Ebola Treatment Market by Type (Vaccine (Under Trials), Drugs (Under Trials)), By Application (Hospitals, Ambulatory Surgery Centres, Specialized Clinics, Army Camps (Veteran Facilities)Ã‚Â ) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028 – Good News Gum - Good News Gum goodnewsgum.com - May 5 at 11:31 AM
	Viral Conjunctivitis Drugs Market Study 2021-2027 By Current And Upcoming Trends, Opportunities, Size, Trends And Forecast \| Adenovir Pharma, Allergan, NanoViricides - Good News Gum goodnewsgum.com - May 4 at 8:19 PM
	Anti-Infective Treatment Market Size, Status, Global Outlook and Forecast 2020-2026 – The Shotcaller - The Shotcaller theshotcaller.net - May 4 at 9:06 AM
	Viral Conjunctivitis Pipeline Drugs Market is Thriving Worldwide with Leading Players Adenovir Pharma AB, Allergan Plc, NanoViricides, Inc, Shire Plc, NovaBay Pharmaceuticals, Inc - Clark County Blog clarkcountyblog.com - May 3 at 7:19 PM
	Ebola Treatment Market 2021 Is Rapidly Increasing Worldwide in Near Future \| Top Companies Analysis- Arbutus Biopharma, GlaxoSmithKline, Johnson & Johnson Services, Hemispherx Biopharma, BioCryst Pharmaceuticals, etc. - Good News Gum goodnewsgum.com - May 3 at 2:19 PM
	If You Had Bought Brixmor Property Group (NYSE:BRX) Stock A Year Ago, You Could Pocket A 106% Gain Today - Nasdaq nasdaq.com - April 28 at 12:59 PM
	We're Not Very Worried About NanoViricides' (NYSEMKT:NNVC) Cash Burn Rate - Nasdaq nasdaq.com - April 28 at 12:59 PM
	Antiviral Therapeutics Markets, Technologies, & Competitive Landscape Report 2021-2030 Featuring profiles of 195 Companies with 179 Collaborations - Yahoo News news.yahoo.com - April 27 at 6:03 PM
	Nano Therapy Market Growth strategies and with Leading Key Players: Pfizer, Ablynx, Smith & Nephew, NANOVIRICIDES – Clark County Blog - Clark County Blog clarkcountyblog.com - April 26 at 2:57 PM
	Viral Conjunctivitis Pipeline Drugs industry analysis base on regional trends 2021-25 – FLA News - FLA News flanewsonline.com - April 24 at 12:40 PM
	Global Antiviral Therapeutics Markets & Technologies Report 2021: Approaches, Vaccines, Human Coronaviruses, Nanotechnology, Delivery, Competitive Landscape, 2020-2030 - ResearchAndMarkets.com - Business Wire businesswire.com - April 21 at 2:49 PM
	Drug Antiinfective Market Report , Competitive Analysis, Proposal Strategy, Top Addressable Targets, Key Requirements - Clark County Blog clarkcountyblog.com - April 17 at 1:26 PM
	Anti-Infective Drugs Market Outlook, Opportunity and Demand Analysis Forecast 2020 – 2025 – Los Hijos de la Malinche - Los Hijos de la Malinche loshijosdelamalinche.com - April 15 at 5:48 PM
	Anti-Infective Drugs Market 2021 Overview, Opportunities, In-Depth Analysis by 2027 : Roche Pharma AG, GlaxoSmithKline, Novabay Pharmaceuticals, Novartis AG, Theravance, Sanofi-Aventis, NanoViricides, Pfizer - Jumbo News jumbonews.co.uk - April 13 at 8:50 AM
	Covid-19 Outbreak Global Ebola virus infection drug Forecast 2020-2027 By Regions, Type and Application with Sales and Revenue Analysis \| – ROUGH Magazine - ROUGH Magazine rough.asia - April 8 at 7:30 PM
	Nanostructured Drug Market Major Players Revenue Analysis Nanoviricides Inc., Ablynx NV, Pfizer Inc., Nanother - openPR openpr.com - March 30 at 5:17 AM
	Is it Time to Dump NanoViricides Inc (NNVC) Stock After it Is Down 1.40% in a Week? - InvestorsObserver investorsobserver.com - March 26 at 2:08 PM
	Buy-the-Dip Candidates: Lordstown Motors, GE, Ulta Beauty - TheStreet thestreet.com - March 15 at 9:30 AM
	Nanostructured Drug Market Likely to Boost Future Growth by 2026 \| Moderna, NanoViricides, Celgene – Breakout Live - Breakout Live breakout.live - March 13 at 3:40 PM
	Indiana AG continues business advisory roles - Dubois County Herald - The Herald duboiscountyherald.com - March 12 at 7:37 PM
	NanoViricides Says Its COVID-19 Drug Candidates Are Effective In Animal Studies In Support Of FDA Pre-IND Application - Benzinga benzinga.com - March 11 at 10:35 PM
	Indiana attorney general continues business advisory roles - Chicago Tribune chicagotribune.com - March 11 at 5:34 PM
	Indiana attorney general continues business advisory roles \| Govt-and-politics \| kenoshanews.com - Kenosha News kenoshanews.com - March 11 at 1:28 PM
	Indiana Attorney General Rokita being paid tens of thousands of dollars for advisory roles - IndyStar indystar.com - March 10 at 8:07 PM

Date	Company	Brokerage	Action
11/9/2020	Eloxx Pharmaceuticals	HC Wainwright	Reiterated Rating
6/10/2020	Eloxx Pharmaceuticals	Citigroup	Downgrade
5/12/2020	Eloxx Pharmaceuticals	Canaccord Genuity	Reiterated Rating
5/8/2020	Eloxx Pharmaceuticals	Janney Montgomery Scott	Lower Price Target
5/8/2020	Eloxx Pharmaceuticals	Piper Sandler	Lower Price Target
8/8/2019	Eloxx Pharmaceuticals	SunTrust Banks	Lower Price Target

(Data available from 5/7/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources